Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase

The Journal of Clinical Investigation
Kenneth C FangGeorge H Caughey

Abstract

Gelatinolytic metalloproteinases implicated in connective tissue remodeling and tumor invasion are secreted from several types of cells in the form of inactive zymogens. In this report, characterization of gelatinase activity secreted by the BR line of dog mastocytoma cells reveals a phorbol-inducible, approximately 92-kD, Ca2+ - and Zn2+ -dependent proenzyme cleaved over time to smaller, active forms. Incubation of cells with the general serine protease inhibitor, PMSF, prevented proenzyme cleavage and permitted its purification free of activation products. The NH2-terminal 13 amino acids of the purified mastocytoma progelatinase are 50-67% identical to those of human, mouse, and rabbit 92-kD progelatinase (gelatinase B; matrix metalloproteinase-9). Degranulation of mastocytoma cells using ionophore A23187 greatly accelerated proenzyme cleavage, suggesting that a serine protease present in secretory granules hydrolyzed the progelatinase to active fragments. To identify the activating protease, cells were coincubated with ionophore and a panel of selective serine protease inhibitors. Soybean trypsin inhibitor and succinyl-L-Ala-Ala-Pro-Phe-chloromethylketone, which inhibit mast cell chymase, prevented progelatinase activation. ...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T T Yang, S P Hawkes
Apr 1, 1990·Trends in Genetics : TIG·L M Matrisian
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H E Van Wart, H Birkedal-Hansen
Oct 1, 1990·The Journal of Allergy and Clinical Immunology·J M Mican, D D Metcalfe
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C S HEG I Goldberg
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G I GoldbergC S He
Nov 1, 1987·Archives of Biochemistry and Biophysics·G H CaugheyJ A Nadel
Aug 31, 1982·Biochemical and Biophysical Research Communications·H Birkedal-Hansen, R E Taylor
Jun 2, 1995·The Journal of Biological Chemistry·W W RaymondG H Caughey
Apr 1, 1993·Chest·A PesciD Olivieri
Dec 1, 1993·Journal of Cellular Physiology·B S WeeksH K Kleinman
Feb 15, 1993·Biochemical and Biophysical Research Communications·H TanakaK Sugita
Jun 1, 1993·The American Review of Respiratory Disease·P ChanezJ Bousquet

❮ Previous
Next ❯

Citations

Jul 4, 2002·International Journal of Radiation Oncology, Biology, Physics·Nils HovdenakMartin Hauer-Jensen
Jun 5, 2007·Nature Medicine·Jiusong SunGuo-Ping Shi
Mar 17, 2005·Mediators of Inflammation·Kottarappat N DileepanDaniel J Stechschulte
Aug 27, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Jiusong SunGuo-Ping Shi
Aug 6, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Jiusong SunGuo-Ping Shi
Apr 3, 2004·American Journal of Respiratory Cell and Molecular Biology·Anthony C CruzKenneth C Fang
Oct 13, 2007·The Journal of Clinical Investigation·Jiusong SunGuo-Ping Shi
Mar 20, 2001·The Journal of Clinical Investigation·C GuoM Rabinovitch
Nov 30, 2002·Journal of Neuroimmunology·Jacques P ZappullaRoland S Liblau
Jan 26, 2016·Journal of Molecular and Cellular Cardiology·Lianwu FuLouis J Dell'Italia
May 2, 2014·The American Journal of the Medical Sciences·Justin Barnes, Louis J DellʼItalia
Jun 10, 2008·Journal of Molecular and Cellular Cardiology·Scott P LevickGregory L Brower
Oct 24, 2007·Human Pathology·Stephan DuerrBernhard Schick
Nov 5, 2008·Veterinary Dermatology·Monika M WelleSilvia Rüfenacht
Feb 14, 2009·European Journal of Heart Failure·Jie XiaoAkira Matsumori
May 8, 2013·Acta Physiologica·K Hollinger, J T Selsby
Jan 6, 2015·The Journal of Pharmacy and Pharmacology·Hsin-Pai LeeZhi-Hong Wen
Jun 20, 2006·Veterinary Immunology and Immunopathology·Tzu-yin LinCheryl A London
Mar 10, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Léon C L van KempenLisa M Coussens
Mar 17, 2000·The Journal of Veterinary Medical Science·Y HikasaH Matsuda
Jul 7, 2015·BioMed Research International·Devandir Antonio de Souza JuniorMaria Celia Jamur
May 11, 2015·European Journal of Pharmacology·George H Caughey
Apr 7, 2012·Biochimica Et Biophysica Acta·Esmaeil MortazFrank A Redegeld
May 27, 2011·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Valéria Souza FreitasLélia Batista de Souza
Mar 18, 2010·Blood·Gunnar PejlerSara Wernersson
Apr 6, 2005·Toxicology and Applied Pharmacology·Andrea Small-Howard, Helen Turner
Oct 10, 2006·Veterinary Immunology and Immunopathology·Tzu-Yin Lin, Cheryl A London
Jul 27, 2014·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Elaine Zayas Marcelino da SilvaConstance Oliver
Nov 23, 2012·Journal of Cardiovascular Pharmacology and Therapeutics·Yair MinaNatalie Landa-Rouben
Apr 7, 2017·Journal of Plastic Surgery and Hand Surgery·Shotaro Jimi, Hajime Matsumura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.